Immunohistochemistry as a diagnostic tool in pathology

Immunohistochemistry (IHC) is an important tool in pathology and allows visualization of antigens when obtaining tissue specimens from patients and employs labeled antibodies directed against those antigens. IHC is helpful to improve tumor classification, identify pathogens and discover prognostic markers when distinguishing features are absent or minimized by morphological assessment. As routine IHC has emerged over the years, monoclonal antibodies and further development of automated stainers allow for increased sensitivity and specificity of antigens assessed by IHC. Since cancer classification relies upon IHC to subtype cancers, define the origin of metastases and to administer targeted therapy, IHC remains a valuable and necessary process for clinical pathology. Innovations continue to be made in IHC, such as new biomarkers, multiplexing and fluorescent technology.

Authors

Institutions

Publication Details

Journal
Bioinformation
Published
2025-10-31
DOI
https://doi.org/10.6026/973206300213595
Primary Topic
HER2/EGFR in Cancer Research
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Immunohistochemistry as a diagnostic tool in pathology

Arvind Gopinath, Ki H., Pukur Thekdi, Himanshu Shekhar et al.
Bioinformation
HER2/EGFR in Cancer Research
article

Immunohistochemistry as a diagnostic tool in pathology

Arvind Gopinath, Ki H., Pukur Thekdi, Himanshu Shekhar, P. Narendra Babu, Divya Jayagopal
article en

Abstract

Immunohistochemistry (IHC) is an important tool in pathology and allows visualization of antigens when obtaining tissue specimens from patients and employs labeled antibodies directed against those antigens. IHC is helpful to improve tumor classification, identify pathogens and discover prognostic markers when distinguishing features are absent or minimized by morphological assessment. As routine IHC has emerged over the years, monoclonal antibodies and further development of automated stainers allow for increased sensitivity and specificity of antigens assessed by IHC. Since cancer classification relies upon IHC to subtype cancers, define the origin of metastases and to administer targeted therapy, IHC remains a valuable and necessary process for clinical pathology. Innovations continue to be made in IHC, such as new biomarkers, multiplexing and fluorescent technology.

BioinformationVol. 21(10)
Dharmsinh Desai University (IN), Nilamber Pitamber University (IN), ACS Medical College and Hospital (IN), Sree Balaji Dental College and Hospital (IN), JSS Medical College and Hospital (IN)
Openalex Percentile: Top 56%
HER2/EGFR in Cancer Research
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.